ANTICUERPO MONOCLONAL PARA LA DETECCIÓN DE LA PROTEÍNA CD79A.
Mexico·Clase II·III. Agentes de diagnóstico·PRODUCTOS ROCHE,
S.A. DE C.V.·Registered December 16, 2022- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- VENTANA CONFIRM ANTI-CD79A (SP18) RABBIT MONOCLONAL PRIMARY ANTIBODY.
- Trade Name (English)
- VENTANA CONFIRM ANTI-CD79A (SP18) RABBIT MONOCLONAL PRIMARY ANTIBODY.
- Analysis ID
- 1672R2022 SSA
- Registration Date
- December 16, 2022
- Name (Spanish)
- PRODUCTOS ROCHE, S.A. DE C.V.
- Name (English)
- PRODUCTOS ROCHE, S.A. DE C.V.
Access comprehensive regulatory information for ANTICUERPO MONOCLONAL PARA LA DETECCIÓN DE LA PROTEÍNA CD79A. (ANTICUERPO MONOCLONAL PARA LA DETECCIÓN DE LA PROTEÍNA CD79A.) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1672R2022 SSA and manufactured by PRODUCTOS ROCHE, S.A. DE C.V.. The device was registered on December 16, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.